The first year with eased-up COVID-19 restrictions, but with a significant economic crisis. How did the life science dealmaking fare in the first half of 2022, following the banner year of 2021? Decrease in …
The MD Regulation (MDR) 2017/745 is a recent EU directive on medical devices which entered into full force on 26th May 2021 after a transition period of three years, extended in early 2020 for …
Companion diagnostics (CDx) are used as a companion to a therapeutic agent to determine its applicability (e.g. predict response to therapy, toxicity...) to a specific person. Commonly, companion diagnostics is named as one of …
Clinical research success rates of different disease areas have far-reaching implications in the structure of corporate R&D budgets, pharmaceutical asset valuation and, eventually, M&A activity. The report published in February 2021 considers success rates of clinical …
The 2022 annual conference of the American Society of Clinical Oncology (ASCO) was held in Chicago between June 3rd-7th, widely recognised as one of the most important oncology gatherings worldwide and perhaps the most …
The In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746 is the new EU legislation applicable to in vitro diagnostic (IVD) medical devices (shortened to IVDs here for simplicity). IVDR officially entered into force on 25th May 2017, …
The Canadian Health Technology Assessment (HTA) agency CADTH released a "Horizon Scan" identifying health tech trends set to significantly impact Canada. These trends aim to leverage data, enhance clinical workflows, and promote accessible healthcare …
The black swan event nobody could have really predicted. 400 million cases around the world, and a significant strain on healthcare systems, and the physical and mental capacities of people globally. Could there be a silver …
